Predicting drug resistance using deep mutational scanning

Gur Pines, Reilly G. Fankhauser, Carrie A. Eckert

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Drug resistance is a major healthcare challenge, resulting in a continuous need to develop new inhibitors. The development of these inhibitors requires an understanding of the mechanisms of resistance for a critical mass of occurrences. Recent genome editing technologies based on high-throughput DNA synthesis and sequencing may help to predict mutations resulting in resistance by testing large mutagenesis libraries. Here we describe the rationale of this approach, with examples and relevance to drug development and resistance in malaria.

Original languageEnglish
Article number2265
JournalMolecules
Volume25
Issue number9
DOIs
StatePublished - May 1 2020
Externally publishedYes

Funding

Funding: This research was funded by the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH, grant number 1R21AI128296-01A1.

Keywords

  • DXR
  • Drug resistance
  • Fosmidomycin
  • Genome editing
  • Sequence to activity mapping

Fingerprint

Dive into the research topics of 'Predicting drug resistance using deep mutational scanning'. Together they form a unique fingerprint.

Cite this